223 related articles for article (PubMed ID: 34446574)
1. Unbalanced Regulation of α7 nAChRs by Ly6h and NACHO Contributes to Neurotoxicity in Alzheimer's Disease.
Wu M; Liu CZ; Barrall EA; Rissman RA; Joiner WJ
J Neurosci; 2021 Oct; 41(41):8461-8474. PubMed ID: 34446574
[TBL] [Abstract][Full Text] [Related]
2. Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction.
Roberts JP; Stokoe SA; Sathler MF; Nichols RA; Kim S
J Biol Chem; 2021; 296():100402. PubMed ID: 33571523
[TBL] [Abstract][Full Text] [Related]
3. Endogenous neurotoxin-like protein Ly6H inhibits alpha7 nicotinic acetylcholine receptor currents at the plasma membrane.
Moriwaki Y; Kubo N; Watanabe M; Asano S; Shinoda T; Sugino T; Ichikawa D; Tsuji S; Kato F; Misawa H
Sci Rep; 2020 Jul; 10(1):11996. PubMed ID: 32686737
[TBL] [Abstract][Full Text] [Related]
4. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
Liu Q; Xie X; Emadi S; Sierks MR; Wu J
Neuropharmacology; 2015 Oct; 97():457-63. PubMed ID: 25959067
[TBL] [Abstract][Full Text] [Related]
5. Ly6h regulates trafficking of alpha7 nicotinic acetylcholine receptors and nicotine-induced potentiation of glutamatergic signaling.
Puddifoot CA; Wu M; Sung RJ; Joiner WJ
J Neurosci; 2015 Feb; 35(8):3420-30. PubMed ID: 25716842
[TBL] [Abstract][Full Text] [Related]
6. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
[TBL] [Abstract][Full Text] [Related]
7. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A
J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
Shen J; Wu J
Int Rev Neurobiol; 2015; 124():275-92. PubMed ID: 26472533
[TBL] [Abstract][Full Text] [Related]
9. On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease.
Oz M; Lorke DE; Yang KH; Petroianu G
Curr Alzheimer Res; 2013 Jul; 10(6):618-30. PubMed ID: 23627750
[TBL] [Abstract][Full Text] [Related]
10. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
11. Brain α7 Nicotinic Acetylcholine Receptor Assembly Requires NACHO.
Gu S; Matta JA; Lord B; Harrington AW; Sutton SW; Davini WB; Bredt DS
Neuron; 2016 Mar; 89(5):948-55. PubMed ID: 26875622
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease.
Farhat SM; Ahmed T
Curr Drug Targets; 2017; 18(13):1537-1544. PubMed ID: 27719660
[TBL] [Abstract][Full Text] [Related]
13. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
[TBL] [Abstract][Full Text] [Related]
14. Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease.
Mousavi M; Hellström-Lindahl E; Guan ZZ; Shan KR; Ravid R; Nordberg A
Neuroscience; 2003; 122(2):515-20. PubMed ID: 14614915
[TBL] [Abstract][Full Text] [Related]
15. α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?
Hernandez CM; Dineley KT
Curr Drug Targets; 2012 May; 13(5):613-22. PubMed ID: 22300028
[TBL] [Abstract][Full Text] [Related]
16. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease.
Ma KG; Qian YH
Neuropeptides; 2019 Feb; 73():96-106. PubMed ID: 30579679
[TBL] [Abstract][Full Text] [Related]
17. Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells.
Ren JM; Zhang SL; Wang XL; Guan ZZ; Qi XL
Mol Med Rep; 2020 Sep; 22(3):2063-2075. PubMed ID: 32582986
[TBL] [Abstract][Full Text] [Related]
18. Increased Aβ
Wang HY; Trocmé-Thibierge C; Stucky A; Shah SM; Kvasic J; Khan A; Morain P; Guignot I; Bouguen E; Deschet K; Pueyo M; Mocaer E; Ousset PJ; Vellas B; Kiyasova V
Alzheimers Res Ther; 2017 Jul; 9(1):54. PubMed ID: 28750690
[TBL] [Abstract][Full Text] [Related]
19. A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides.
Liu Q; Huang Y; Xue F; Simard A; DeChon J; Li G; Zhang J; Lucero L; Wang M; Sierks M; Hu G; Chang Y; Lukas RJ; Wu J
J Neurosci; 2009 Jan; 29(4):918-29. PubMed ID: 19176801
[TBL] [Abstract][Full Text] [Related]
20. In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.
Nakaizumi K; Ouchi Y; Terada T; Yoshikawa E; Kakimoto A; Isobe T; Bunai T; Yokokura M; Suzuki K; Magata Y
J Alzheimers Dis; 2018; 61(4):1355-1365. PubMed ID: 29376856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
